Tumor‐infiltrating lymphocytes (TILs), including CD8+ T cells, macrophages, neutrophils, and dendritic cells affect the prognosis and efficacy of immunochemotherapy (Santoiemma & Powell, 2015). The gene discussed is CD8A; the disease is neoplasm.